Search

Meeting Coverage:

Aspen Retinal Detachment Society

ARDS: 2016

Acute Ocriplasmin Retinopathy

Mark Johnson, MD, Tim Murray, MD

Show Description +

Mark Johnson, MD, joins Tim Murray, MD, MBA, to discuss manifestations of acute ocriplasmin retinopathy. Dr. Johnson says there have been numerous reports of patients who present with a range of abnormalities after ocriplasmin injection, including severe loss of vision, enlargement of macular holes, and dislocation of lenses. He explains what could be causing these abnormalities, and warns that physicians should use ocriplasmin injections with caution.

Posted: 3/07/2016

Keywords:

Ocriplasmin

Up Next

Treatments Using Gene Therapy and Engineered Cells

Treatments Using Gene Therapy and Engineered Cells

Szilard Kiss, MD, Tim Murray, MD

Advances in Pediatric Vitreoretinal Surgery

Advances in Pediatric Vitreoretinal Surgery

R.V. Paul Chan, MD, Tim Murray, MD

VMT Management: Watch and Wait

VMT Management: Watch and Wait

Harry W. Flynn Jr., MD, Tim Murray, MD

Imaging and Uveitis: How to Apply Imaging Information

Imaging and Uveitis: How to Apply Imaging Information

Glenn Jaffe, MD, Tim Murray, MD

Macular Hole Repair in the Small-Gauge Era

Macular Hole Repair in the Small-Gauge Era

Tarek Hassan, MD, Tim Murray, MD

Update on Health Care Policy

Update on Health Care Policy

David W. Parke II, MD, Tim Murray, MD

Protocol T 2-Year Data

Protocol T 2-Year Data

Neil Bressler, MD, Tim Murray, MD

Back to All Videos

Acute Ocriplasmin Retinopathy

Mark Johnson, MD, Tim Murray, MD

Mark Johnson, MD, joins Tim Murray, MD, MBA, to discuss manifestations of acute ocriplasmin retinopathy. Dr. Johnson says there have been numerous reports of patients who present with a range of abnormalities after ocriplasmin injection, including severe loss of vision, enlargement of macular holes, and dislocation of lenses. He explains what could be causing these abnormalities, and warns that physicians should use ocriplasmin injections with caution.

Posted: 3/07/2016

Keywords:

Ocriplasmin

Please log in to leave a comment.

More From ARDS: 2016 Coverage

VMT Management: Watch and Wait

VMT Management: Watch and Wait

Harry W. Flynn Jr., MD, Tim Murray, MD

Imaging and Uveitis: How to Apply Imaging Information

Imaging and Uveitis: How to Apply Imaging Information

Glenn Jaffe, MD, Tim Murray, MD

Macular Hole Repair in the Small-Gauge Era

Macular Hole Repair in the Small-Gauge Era

Tarek Hassan, MD, Tim Murray, MD

Update on Health Care Policy

Update on Health Care Policy

David W. Parke II, MD, Tim Murray, MD

Bryn Mawr Communications, LLC, and Eyetube.net are not affiliated with the official program of ARDS: 2016.